HKG:1877 Revenue

In the year 2024, Shanghai Junshi Biosciences had annual revenue of 1.95B CNY with 29.67% growth. Shanghai Junshi Biosciences had revenue of 677.12M in the quarter ending December 31, 2024, with 31.20% growth.

Revenue

1.95B CNY

Revenue Growth

+29.67%

P/S Ratio

7.69

Revenue / Employee

755.75K CNY

Employees

2,578

Market Cap

29.31B HKD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	1.95B	445.77M	29.67%
Dec 31, 2023	1.50B	49.06M	3.38%
Dec 31, 2022	1.45B	-2.57B	-63.89%
Dec 31, 2021	4.02B	2.43B	152.36%
Dec 31, 2020	1.59B	819.81M	105.77%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
BeiGene	29.60B
Hansoh Pharmaceutical Group Company	13.05B
WuXi Biologics	19.87B
JD Health International	61.89B
Innovent Biologics	10.03B
Akeso	2.26B
Alibaba Health Information Technology	31.39B
Sino Biopharmaceutical	30.72B

Revenue Rankings